Increased awareness about mental health disorder and improving treatment methods for the same would drive market growth

The Global Anxiety Disorder and Depression Treatment Market size is forecast to reach USD 19.53 Billion by 2028, registering a CAGR of 2.4% over the forecast period, according to a new report by Reports and Data. Major factors driving market revenue growth are increasing awareness about mental health disorders and the rising demand to treat such disorders as anxiety and depression.

Anxiety disorders and depression, are among the most prevalent mental health conditions. Though they are less visible than schizophrenia and bipolar disorder, they can be just as disabling. Anxiety disorders affect up to 13.3% of people in the United States, making it the most common group of mental diseases. The Epidemiological Catchments Area study, which took place around 26 years ago, was the first to disclose the scope of their occurrence. Due to their extensive occurrence, these illnesses have received increasing attention in the recent years and are being considered just as important as other syndromes such as mood and psychotic disorders. The primary care physician is often the primary assessor and treatment provider. With improvement in primary healthcare infrastructure around the world, market for anxiety disorder and depression treatment is also expected to grow.

Key companies profiled in the report include

Johnson Johnson, Inc., Pfizer, GlaxoSmithKline plc., Lundbeck A/S, Inc., Sanofi- Aventis, Merck Company, AstraZeneca PLC., Forest Laboratories, Eli Lilly and Company, Bristol-Myers Squibb Company among

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1405

The report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behavior shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the Anxiety Disorder and Depression Treatment market.

The report discusses in detail the global production capacity, demand and supply ratio, market dynamics, and comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of the market share of each players along with their business portfolio, production and manufacturing capacity, product portfolio, business expansion plans, financial standing, and strategic alliances such as mergers and acquisitions, joint ventures, and collaborations, among others.

Order this Report @ https://www.reportsanddata.com/report-pricing/1405

The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, Asia Pacific, and Middle East Africa. The report discusses in detail the market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends, and technological developments in each region.

The key geographical regions analyzed in the market report are:

• North America (U.S.A., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Anxiety Disorder and Depression Treatment Market Segmentation based on Types:

Drug Class Outlook (Revenue, USD Billion; 2020 – 2028)

• Selective Serotonin Reuptake Inhibitors (SSRIs)
• Antidepressant Drugs
• Tricyclic Antidepressants (TCAs)
• Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
• Monoamine Oxidase Inhibitors (MAOIs)
• Benzodiazepines
• Atypical Antipsychotics
• Anticonvulsants
• Beta-Blockers
• Others

Therapies Outlook (Revenue, USD Billion; 2020 – 2028)

• Electroconvulsive Therapy (ECT)
• Cognitive Behavior Therapy (CBT)
• Psychotherapy
• Deep Brain Stimulation
• Transcranial Magnetic Stimulation (TMS)
• Cranial electrotherapy stimulation (CES)

Devices Outlook (Revenue, USD Billion; 2020 – 2028)

• Cranial electrotherapy stimulator
• Fisher-Wallace stimulator market

Application Outlook (Revenue, USD Billion; 2020 – 2028)

• Phobia
• Major Depressive Disorder
• Obsessive Compulsive Disorder (OCD)
• Post-traumatic stress disorder
• Others

End-users Outlook (Revenue, USD Billion; 2020 – 2028)

• Hospitals
• Mental healthcare centers
• NGOs
• Asylums

Further key findings from the report suggest

• The rising rate of depression and anxiety disorder as well as the increasing awareness to treat such disorders will drive market growth.
• In the drug class segment, antidepressants accounted for the highest market share in 2020. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) accounted for 28% of the market revenue share.
• As a result of higher incidents of suicide, there has been a rise in demand for therapies. In the year 2020, Cognitive Behavior Therapy [CBT] accounted for the largest market share among other therapies segment.
• In 2020, North America accounted fort the largest revenue share in the anxiety disorder and depression treatment market. Because of increased incidence rate of anxiety disorders and depression in the region, and favourable government policies, North America is expected to continue accounting for a higher revenue share during the forecast period.
• In terms of market share, the Asia Pacific region also has a considerable share in the worldwide anxiety disorder and depression treatment market. Major reasons for market growth in the APAC region is increasing disposable income and improvement of healthcare sector.

Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/1405

Thank you for reading our report. For further inquiry or query about customization, kindly get in touch with us to know more. Our team will clear your doubts and ensure the report is customized to meet your requirements.

Browse More Reports:

Microplate Market @ https://www.biospace.com/article/microplate-market-size-share-growth-sales-revenue-and-key-drivers-analysis-research-report-by-2028/

Fine Chemical Market @ https://www.biospace.com/article/fine-chemical-market-growth-2022-future-trends-and-industry-demand-by-2028/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]